Search

Your search keyword '"Dunlap, Mark E."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Dunlap, Mark E." Remove constraint Author: "Dunlap, Mark E." Search Limiters Full Text Remove constraint Search Limiters: Full Text
49 results on '"Dunlap, Mark E."'

Search Results

2. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry)

3. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial

6. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

7. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations

9. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme

10. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial

13. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group

14. Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial

16. 6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients With Systolic Heart Failure

21. Response to Wave Reflection in Systolic Hypertension: Smaller Stature, Shorter Aorta: Higher Pulse Pressure? and Questions Regarding the Aortic Measurements of Mitchell et al

23. Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness

27. Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

28. Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

37. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme.

38. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM

41. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure An Analysis of the CHARM Program

42. LETTERS.

43. Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients.

45. Alpha7-nicotinic acetylcholine receptor subunit is not required for parasympathetic control of the heart in the mouse.

46. Prevention of diminished parasympathetic control of the heart in experimental heart failure.

47. Angiotensin-receptor blockers in heart failure: evidence from the CHARM trial.

48. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity.

49. ACE inhibitors vs ARBs: is one class better for heart failure.

Catalog

Books, media, physical & digital resources